Glycolic acid ethoxylate lauryl ether
Product Information
Molecular Formula
C43H94O8
Molecular Weight
739.2
Description
Surfactant. Stabilizer for microemulsions.
Synonyms
dodecan-1-ol,ethane-1,2-diol,2-hydroxyacetic acid,tetradecan-1-ol,tridecan-1-ol; Laureth-4 carboxylic acid; Laureth-6 carboxylic acid; Laureth-11 carboxylic acid
IUPAC Name
2-(2-ethoxyethoxy)acetic acid
SMILES
OCCO.OCC(O)=O.CCCCCCCCCCCCO.CCCCCCCCCCCCCO.CCCCCCCCCCCCCCO
InChI
InChI=1S/C6H12O4/c1-2-9-3-4-10-5-6(7)8/h2-5H2,1H3,(H,7,8)
InChI Key
LVLQKFRSMSHJIE-UHFFFAOYSA-N
Flash Point
>235.4 °F
Density
1 g/mL at 25 °C
Appearance
Powder
Application
Anionic surfactant.
Refractive Index
1.45
Safety Information
Precautionary Statement
P264, P264+P265, P273, P280, P302+P352, P305+P354+P338, P317, P321, P332+P317, P362+P364, P391, and P501
Signal Word
Danger
Computed Properties
XLogP3
-0.1
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
6
Exact Mass
148.07355886 g/mol
Monoisotopic Mass
148.07355886 g/mol
Topological Polar Surface Area
55.8Ų
Heavy Atom Count
10
Formal Charge
0
Complexity
91.7
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021254979-A1 | Chemokine-selective cxcr4 ectodomain-derived (poly)peptide | 2020-06-16 |
| WO-2021221084-A1 | Blocked isocyanate composition, heat-curable resin composition, cured product, production method therefor, amidate compound, and catalyst for dissociation of blocking agent for blocked isocyanates | 2020-04-30 |
| WO-2021221090-A1 | Blocked polyisocyanate composition, heat-curable resin composition, cured product, and production method therefor | 2020-04-30 |
| WO-2021200783-A1 | Amidate compound, production method therefor, blocking-agent dissociation catalyst, and thermally curable resin composition | 2020-03-30 |
| WO-2021177267-A1 | Prevention or treatment of aneurysms using mir-33b inhibitor | 2020-03-02 |
| WO-2021157587-A1 | Method for producing carboxylate compound and method for producing amidate compound | 2020-02-03 |
| TW-202136217-A | Method for producing carboxylate compound and method for producing amide salt compound | 2020-02-03 |
| US-2021238472-A1 | Methods for clay swelling inhibition using gemini surfactants containing a saturated linker | 2020-01-30 |
| US-2021222052-A1 | Gemini surfactants containing an arylene linker for clay swelling inhibition | 2020-01-21 |
| US-2021189222-A1 | Gemini surfactants containing an unsaturated linker for clay swelling inhibition | 2019-12-18 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 21705463 | 2012-01-01 | Urinary biomarkers of exposure to glycol ethers and chlorinated solvents during pregnancy: determinants of exposure and comparison with indirect methods of exposure assessment | Occupational and environmental medicine |
| 20812373 | 2011-01-01 | Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes | Journal of peptide science : an official publication of the European Peptide Society |
| 15705492 | 2005-03-28 | Biomonitoring of 2-(2-alkoxyethoxy)ethanols by analysing urinary 2-(2-alkoxyethoxy)acetic acids | Toxicology letters |
